Propionic Acid

Propionic Acid

SCHEMBL4153652

CCC(=O)O.O=c1[nH]c2ccc(SC3CCCCC3)cc2c2cc[nH]c12

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 0.39
MAOB P27338 3/20 0.39
MAPK10 P53779 1/20 0.36
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
ALDH1A1 P00352 8/20 0.33
ALOX15 P16050 1/20 0.33
BRD4 O60885 3/20 0.33
KDM4E B2RXH2 6/20 0.32
HPGD P15428 3/20 0.32
HSD17B10 Q99714 3/20 0.32
MAPK1 P28482 1/20 0.32
ATM Q13315 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
LNPEP Q9UIQ6 1/20 0.32
THRB P10828 1/20 0.32
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
TSHR P16473 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4162079 0.81 PLA2G1B (0.39) MAOAMAOBMEN1KMT2AALDH1A1
Propionic Acid SCHEMBL4164365 0.80 MAPT (0.34) MEN1KMT2AALDH1A1KDM4EHPGD
Propionic Acid SCHEMBL4153189 0.78 DAO (0.41) MAOAMAOBMEN1KMT2AALDH1A1
Propionic Acid SCHEMBL4165125 0.76 PARP1 (0.47) MEN1KMT2AALDH1A1KDM4EHPGD
Propionic Acid SCHEMBL4160624 0.76 MPO (0.43) KDM4EMAPK1TSHR
Propionic Acid SCHEMBL4155436 0.76 PIM3 (0.49) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL4153645 0.76 HPGD (0.37) MAOAMAOBMAPK10MEN1KMT2A
Propionic Acid SCHEMBL4157652 0.76 TDP1 (0.56) MEN1KMT2AALDH1A1ALOX15HPGD
Propionic Acid SCHEMBL4153174 0.76 TDP1 (0.56) MEN1KMT2AALDH1A1ALOX15HPGD
SCHEMBL3253510 0.76 MAOA (0.39) MAOAMAOBMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 MAOA 2903/4885MAOB 2304/4885MAPK10 102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.